Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of Low-Frequency, Antiviral Resistance Variants in SARS-CoV-2 Isolates in Ontario, Canada, 2020-2023
Calvin Sjaarda, Lynette Lau, Jared T. Simpson, et al.
JAMA Network Open (2023) Vol. 6, Iss. 7, pp. e2324963-e2324963
Open Access | Times Cited: 12

Showing 12 citing articles:

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
Bin Tan, Xiaoming Zhang, Ahmadullah Ansari, et al.
Science (2024) Vol. 383, Iss. 6690, pp. 1434-1440
Open Access | Times Cited: 39
Structure-based design of SARS-CoV-2 papain-like protease inhibitors
Prakash D. Jadhav, Bo Huang, J. Osipiuk, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116011-116011
Open Access | Times Cited: 13
Low Prevalence of Nirmatrelvir-Ritonavir Resistance-Associated Mutations in SARS-CoV-2 Lineages From Botswana
Wonderful T. Choga, Ontlametse T. Bareng, Natasha O. Moraka, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 7
Open Access | Times Cited: 2
An expanded RT-PCR melting temperature coding assay to rapidly identify all known SARS-CoV-2 variants and sub-variants of concern
Padmapriya P. Banada, Raquel Green, Deanna Streck, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Non-structural Proteins Inhibitors
Xiaojie Lu, Hangchen Hu, Lianghe Mei, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review
D. Stewart
Clinical Case Reports (2023) Vol. 11, Iss. 11
Open Access | Times Cited: 2
Design of SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
Bin Tan, Xiaoming Zhang, Ahmadullah Ansari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
SARS-CoV-2 Nirmatrelvir Resistance—A Concern for Immunocompromised Populations?
Zhuo Zhou, Hong Peng
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2435439-e2435439
Open Access
The problem of SARS-CoV-2 virus resistance to direct-acting antivirals
Е. Л. Гасич, Е. Н. Кроткова, A. D. Kasko, et al.
Biological Products Prevention Diagnosis Treatment (2024)
Open Access
Structure-Based Design of Covalent SARS-CoV-2 Papain-like Protease Inhibitors
Bin Tan, Xueying Liang, Ahmadullah Ansari, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20399-20420
Closed Access
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein Inhibitors
Xudong Wang, Liwei Xiong, Ying Zhu, et al.
Journal of the American Chemical Society (2024)
Closed Access
High Mortality With COVID‐19 Acute Pericarditis
Dale Adler
Journal of the American Heart Association (2023) Vol. 12, Iss. 20
Open Access
Page 1

Scroll to top